These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 11906054

  • 1. Pneumocystis carinii dihydropteroate synthase mutations and treatment with sulfa or sulfone regimens: a proposal for standardized definitions for clinical evaluation.
    Huang L, Morris AM, Beard CB.
    J Eukaryot Microbiol; 2001; Suppl():180S-181S. PubMed ID: 11906054
    [No Abstract] [Full Text] [Related]

  • 2. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients.
    Kazanjian P, Locke AB, Hossler PA, Lane BR, Bartlett MS, Smith JW, Cannon M, Meshnick SR.
    AIDS; 1998 May 28; 12(8):873-8. PubMed ID: 9631140
    [Abstract] [Full Text] [Related]

  • 3. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use.
    Ma L, Borio L, Masur H, Kovacs JA.
    J Infect Dis; 1999 Dec 28; 180(6):1969-78. PubMed ID: 10558954
    [Abstract] [Full Text] [Related]

  • 4. High Prevalence of Pneumocystis jirovecii Dihydropteroate Synthase Gene Mutations in Patients with a First Episode of Pneumocystis Pneumonia in Santiago, Chile, and Clinical Response to Trimethoprim-Sulfamethoxazole Therapy.
    Ponce CA, Chabé M, George C, Cárdenas A, Durán L, Guerrero J, Bustamante R, Matos O, Huang L, Miller RF, Vargas SL.
    Antimicrob Agents Chemother; 2017 Feb 28; 61(2):. PubMed ID: 27855071
    [Abstract] [Full Text] [Related]

  • 5. Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients.
    Kazanjian P, Armstrong W, Hossler PA, Burman W, Richardson J, Lee CH, Crane L, Katz J, Meshnick SR.
    J Infect Dis; 2000 Aug 28; 182(2):551-7. PubMed ID: 10915088
    [Abstract] [Full Text] [Related]

  • 6. Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P carinii pneumonia in patients with HIV-1: a prospective study.
    Navin TR, Beard CB, Huang L, del Rio C, Lee S, Pieniazek NJ, Carter JL, Le T, Hightower A, Rimland D.
    Lancet; 2001 Aug 18; 358(9281):545-9. PubMed ID: 11520525
    [Abstract] [Full Text] [Related]

  • 7. Contribution of dihydropteroate synthase gene typing for Pneumocystis carinii f.sp. hominis epidemiology.
    Santos LD, Lacube P, Latouche S, Kac G, Mayaud C, Marteau M, Poirot JL, Maury E, Guillot J, Roux P.
    J Eukaryot Microbiol; 1999 Aug 18; 46(5):133S-134S. PubMed ID: 10519287
    [No Abstract] [Full Text] [Related]

  • 8. Sulfa resistance and dihydropteroate synthase mutants in recurrent Pneumocystis carinii pneumonia.
    Nahimana A, Rabodonirina M, Helweg-Larsen J, Meneau I, Francioli P, Bille J, Hauser PM.
    Emerg Infect Dis; 2003 Jul 18; 9(7):864-7. PubMed ID: 12890330
    [Abstract] [Full Text] [Related]

  • 9. Increase in prevalence of Pneumocystis carinii mutations in patients with AIDS and P. carinii pneumonia, in the United States and China.
    Kazanjian PH, Fisk D, Armstrong W, Shulin Q, Liwei H, Ke Z, Meshnick S.
    J Infect Dis; 2004 May 01; 189(9):1684-7. PubMed ID: 15116306
    [Abstract] [Full Text] [Related]

  • 10. Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance.
    Huang L, Crothers K, Atzori C, Benfield T, Miller R, Rabodonirina M, Helweg-Larsen J.
    Emerg Infect Dis; 2004 Oct 01; 10(10):1721-8. PubMed ID: 15504256
    [Abstract] [Full Text] [Related]

  • 11. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in immunocompromised patients.
    Armstrong W, Meshnick S, Kazanjian P.
    Microbes Infect; 2000 Jan 01; 2(1):61-7. PubMed ID: 10717542
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia.
    Kovacs JA, Gill VJ, Meshnick S, Masur H.
    JAMA; 2001 Nov 21; 286(19):2450-60. PubMed ID: 11712941
    [Abstract] [Full Text] [Related]

  • 15. Mutations in the dihydropteroate synthase gene of human-derived Pneumocystis carinii isolates from Italy are infrequent but correlate with prior sulfa prophylaxis.
    Ma L, Kovacs JA, Cargnel A, Valerio A, Fantoni G, Atzori C.
    J Infect Dis; 2002 May 15; 185(10):1530-2. PubMed ID: 11992293
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of dihydropteroate synthase genotypes before and after the introduction of combined antiretroviral therapy and their influence on the outcome of Pneumocystis pneumonia in HIV-1-infected patients.
    Alvarez-Martínez MJ, Miró JM, Valls ME, Mas J, de la Bellacasa JP, Sued O, Solé M, Rivas PV, de Lazzari E, Benito N, García F, Agustí C, Wilson PE, Gatell JM, Jiménez de Anta MT, Meshnick SR, Moreno A.
    Diagn Microbiol Infect Dis; 2010 Sep 15; 68(1):60-5. PubMed ID: 20727472
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dihydropteroate synthase (DHPS) gene mutation study in HIV-Infected Indian patients with Pneumocystis jirovecii pneumonia.
    Tyagi AK, Mirdha BR, Luthra K, Guleria R, Mohan A, Singh UB, Samantaray JC, Dar L, Iyer VK, Chaudhry R.
    J Infect Dev Ctries; 2010 Nov 24; 4(11):761-6. PubMed ID: 21252456
    [Abstract] [Full Text] [Related]

  • 19. Drug-resistant Pneumocystis carinii.
    Meshnick SR.
    Lancet; 1999 Oct 16; 354(9187):1318-9. PubMed ID: 10533856
    [No Abstract] [Full Text] [Related]

  • 20. Low-dose dapsone, co-trimoxazole, and survival in Pneumocystis carinii primary prophylaxis.
    Antinori A, Murri R, Ammassari A.
    AIDS; 1996 Aug 16; 10(9):1046-7. PubMed ID: 8853743
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.